- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Monalizumab: inhibiting the novel immune checkpoint NKG2A ; volume:7 ; number:1 ; day:17 ; month:10 ; year:2019 ; pages:1-8 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (17.10.2019), 1-8, 12.2019
- Urheber
-
Hall, Thorbald van
André, Pascale
Horowitz, Amir
Ruan, Dan Fu
Borst, Linda
Zerbib, Robert
Narni-Mancinelli, Emilie
Burg, Sjoerd H. van der
Vivier, Eric
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0761-3
- URN
-
urn:nbn:de:101:1-2020021321122128586098
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hall, Thorbald van
- André, Pascale
- Horowitz, Amir
- Ruan, Dan Fu
- Borst, Linda
- Zerbib, Robert
- Narni-Mancinelli, Emilie
- Burg, Sjoerd H. van der
- Vivier, Eric
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators
GPCRs: emerging targets for novel T cell immune checkpoint therapy
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
The CD83 Molecule – An Important Immune Checkpoint
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma
Immune checkpoint analysis in lip cancer
Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators
GPCRs: emerging targets for novel T cell immune checkpoint therapy
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
The CD83 Molecule – An Important Immune Checkpoint
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma
Immune checkpoint analysis in lip cancer
Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators
GPCRs: emerging targets for novel T cell immune checkpoint therapy
Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
The CD83 Molecule – An Important Immune Checkpoint
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma
A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma